IP Library › Patent Application 11825293
Patent Application
App. No. 11/825,293

Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/825,293
Abstract

The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.

Claims (2)

1 . A peptide analogue of GIP(1-42) (SEQ ID NO:1), comprising at least 12 amino acid residues from the N-terminal end of GIP(3-42).

2 - 38 . (canceled)

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2009
From: GAULT, VICTOR A; O'HARTE, FINBARR PAUL MARY; IRWIN, NIGEL; HARRIOTT, PATRICK; FLATT, PETER RAYMOND
To: UUTECH LIMITED
Reel/Frame 022218/0019 →